Assignee
STATENS SERUMINSTITUT
DK·38 granted patents·16 pending applications·742 citations·filing 1989–2025
Top patents by PatentIndex Score
54 records- 0193US7749520B2Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipidsSTATENS SERUMINSTITUT·Filed 2005·Granted Jul 6, 2010·23 cites·17 claims
- 0289US5985935ATreatment and prophylaxis of diseases caused by parasites, or bacteriaSTATENS SERUMINSTITUT·Filed 1993·Granted Nov 16, 1999·49 cites·47 claims
- 0388US8703151B2Tuberculosis vaccines comprising antigens expressed during the latent infection phaseSTATENS SERUMINSTITUT·Filed 2012·Granted Apr 22, 2014·7 cites·17 claims
- 0488US6991797B2M. tuberculosis antigensSTATENS SERUMINSTITUT·Filed 2001·Granted Jan 31, 2006·56 cites·13 claims
- 0587US7037510B2Hybrids of M. tuberculosis antigensSTATENS SERUMINSTITUT·Filed 2001·Granted May 2, 2006·35 cites·21 claims
- 0686US6281336B1Process for producing immunoglobulins for intravenous administration and other immunoglobulin productsSTATENS SERUMINSTITUT·Filed 1999·Granted Aug 28, 2001·112 cites·14 claims
- 0785US7138120B2Process for producing immunoglobulins for intravenous administration and other immunoglobulin productsSTATENS SERUMINSTITUT·Filed 2001·Granted Nov 21, 2006·41 cites·15 claims
- 0884US6982085B2TB diagnostic based on antigens from M. tuberculosisSTATENS SERUMINSTITUT·Filed 2002·Granted Jan 3, 2006·19 cites·10 claims
- 0984US6806355B2Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal productSTATENS SERUMINSTITUT·Filed 2002·Granted Oct 19, 2004·18 cites·12 claims
- 1082US5955077ATuberculosis vaccineSTATENS SERUMINSTITUT·Filed 1995·Granted Sep 21, 1999·95 cites·30 claims
- 1181US10004793B2M.tuberculosis vaccinesSTATENS SERUMINSTITUT·Filed 2015·Granted Jun 26, 2018·3 cites·19 claims
- 1281US7838013B2Specific epitope based immunological diagnosis of tuberculosisSTATENS SERUMINSTITUT·Filed 2005·Granted Nov 23, 2010·12 cites·4 claims
- 1380US10925954B2Vaccines against Chlamydia spSTATENS SERUMINSTITUT·Filed 2018·Granted Feb 23, 2021·1 cites·15 claims
- 1480US6649409B1Method for producing a nucleotide sequence construct with optimized codons for an HIV genetic vaccine based on a primary, early HIV isolate and synthetic envelope BX08 constructsSTATENS SERUMINSTITUT·Filed 2000·Granted Nov 18, 2003·18 cites·48 claims
- 1578US9526773B2M. tuberculosis vaccinesSTATENS SERUMINSTITUT·Filed 2013·Granted Dec 27, 2016·2 cites·17 claims
- 1675US7968105B2Tuberculosis vaccines comprising antigens expressed during the latent infection phaseSTATENS SERUMINSTITUT·Filed 2006·Granted Jun 28, 2011·2 cites·21 claims
- 1775US6649170B1Adjuvant combinations for immunization composition and vaccinesSTATENS SERUMINSTITUT·Filed 1999·Granted Nov 18, 2003·46 cites·10 claims
- 1875US5231168AMalaria antigenSTATENS SERUMINSTITUT·Filed 1989·Granted Jul 27, 1993·64 cites·7 claims
- 1974US7867502B1Tuberculosis vaccine and diagnostics based on the Mycobacterium tuberculosis sat-6 gene familySTATENS SERUMINSTITUT·Filed 2003·Granted Jan 11, 2011·10 cites·22 claims
- 2074US2025255951A1Vaccines against Chlamydia sp.STATENS SERUMINSTITUT·Filed 2025·Application pending·0 cites
- 2173US6641814B1Nucleic acids fragments and polypeptide fragments derived from M. tuberculosisSTATENS SERUMINSTITUT·Filed 1998·Granted Nov 4, 2003·43 cites·43 claims
- 2272US6921808B2Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc-globulin and a Gc-globulin medicinal productSTATENS SERUMINSTITUT·Filed 2004·Granted Jul 26, 2005·5 cites·6 claims
- 2368US6429192B1Purification process for production of mannan-binding lectin and an MBL medicinal productSTATENS SERUMINSTITUT·Filed 1999·Granted Aug 6, 2002·33 cites·30 claims
- 2467US6451611B1Quantitative analysis of hexose-monophosphates from biological samplesSTATENS SERUMINSTITUT·Filed 2000·Granted Sep 17, 2002·17 cites·41 claims
- 2566US2021205433A1Vaccines against Chlamydia sp.STATENS SERUMINSTITUT·Filed 2021·Application pending·0 cites
- 2662US7749507B2Malaria vaccineSTATENS SERUMINSTITUT·Filed 2005·Granted Jul 6, 2010·1 cites·5 claims
- 2761US2010015171A1Vaccines comprising tb 10.4STATENS SERUMINSTITUT·Filed 2009·Application pending·0 cites
- 2860US2007184073A1TB diagnostic based on antigens from M. tuberculosisSTATENS SERUMINSTITUT·Filed 2005·Application pending·0 cites
- 2956US2014205656A1Modified cationic liposome adjuvantsSTATENS SERUMINSTITUT·Filed 2014·Application pending·0 cites
- 3056US2025170236A1A novel cationic adjuvant compositionSTATENS SERUMINSTITUT·Filed 2023·Application pending·0 cites
- 3156US2014275478A1Vaccines against Chlamydia sp.STATENS SERUMINSTITUT·Filed 2014·Application pending·0 cites
- 3255US2008299151A1Influenza vaccinesSTATENS SERUMINSTITUT·Filed 2008·Application pending·0 cites
- 3355US2024299528A1A dna plasmid sars-corona virus-2/covid-19 vaccineSTATENS SERUMINSTITUT·Filed 2021·Application pending·0 cites
- 3454US6165997APhospholipids having antimicrobial activity with or without the presence of antimicrobialsSTATENS SERUMINSTITUT·Filed 1998·Granted Dec 26, 2000·18 cites·15 claims
- 3554US2019201340A1Methods for producing liposomesSTATENS SERUMINSTITUT·Filed 2018·Application pending·0 cites
- 3651USRE46583EVaccines comprising TB10.4STATENS SERUMINSTITUT·Filed 2015·Granted Oct 24, 2017·0 cites·23 claims
- 3751US2004086949A1Method for preparing a ligand presenting assembly (LPA), an LPA and uses thereofSTATENS SERUMINSTITUT·Filed 2003·Application pending·0 cites
- 3850US7776821B2Method comprising nanofiltration to obtain an MBL product safe from infectious agents and the product obtainable by this methodSTATENS SERUMINSTITUT·Filed 2005·Granted Aug 17, 2010·0 cites·24 claims
- 3949US10729765B2Alpha-tocopherol-based adjuvanted solvent for DNA vaccinesSTATENS SERUMINSTITUT·Filed 2015·Granted Aug 4, 2020·0 cites·11 claims
- 4049US10519202B2Tuberculosis TB vaccine to prevent reactivationSTATENS SERUMINSTITUT·Filed 2014·Granted Dec 31, 2019·0 cites·4 claims
- 4149US9523131B2PCR diagnostics of dermatophytes and other pathogenic fungiSTATENS SERUMINSTITUT·Filed 2014·Granted Dec 20, 2016·0 cites·10 claims
- 4249US2023225972A1Liposomal composition for preventing or early treatment of pathogenic infectionSTATENS SERUMINSTITUT·Filed 2021·Application pending·0 cites
- 4348US2002094336A1Nucleic acid fragments and polypeptide fragments derived from M. tuberculosisSTATENS SERUMINSTITUT·Filed 2001·Application pending·0 cites
- 4447US10641770B2Diagnostic reagents for improved in vivo or in vitro cell-mediated immunological diagnosis of tuberculosisSTATENS SERUMINSTITUT·Filed 2014·Granted May 5, 2020·0 cites·16 claims
- 4546US10786579B2Skin testing for tuberculosis in immunocompromised personsSTATENS SERUMINSTITUT·Filed 2016·Granted Sep 29, 2020·0 cites·20 claims
- 4646US6120776ADiagnostic skin test for tuberculosisSTATENS SERUMINSTITUT·Filed 1994·Granted Sep 19, 2000·12 cites·50 claims
- 4746US2003065039A1Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-onesSTATENS SERUMINSTITUT·Filed 2002·Application pending·0 cites
- 4843US7678544B2ADAM12, a novel marker for abnormal cell functionSTATENS SERUMINSTITUT·Filed 2005·Granted Mar 16, 2010·0 cites·9 claims
- 4942US2010311041A1Pcr diagnostics of dermatophytes and other pathogenic fungiSTATENS SERUMINSTITUT·Filed 2006·Application pending·0 cites
- 5041US9422348B2Production of a cysteine rich proteinSTATENS SERUMINSTITUT·Filed 2012·Granted Aug 23, 2016·0 cites·20 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when STATENS SERUMINSTITUT files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →